CTRI/2018/01/011056尚未招募未知
Safety and efficacy of Hyperthermic Intra-Peritoneal Chemotherapy in the management of Gastric cancer.
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- AIIMS
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients 18-75 years old, with a diagnosis of adenocarcinoma of the stomach with T stage equal to or higher than T2 (including patients who received neoadjuvant therapy) as assessed by CECT and/or intraoperatively
排除标准
- •1.Unwilling to consent for the study.
- •2.ECOG status >2
- •3.Developing hemodynamic instability during surgical procedures.
- •4.Bone marrow suppression.
- •5. R2 resection .
- •6.Patients found to have widespread metastasis (not amenable to cytoreduction) or an unresectable lesion, evidence of extensive para-aortic/retropancreatic lymph node metastasis on imaging.
- •7.Active systemic infection or any associated medical problem that has an unacceptable risk for a major surgical procedure.
研究者
相似试验
已完成
不适用
Safety and efficacy of heated chemotherapy given during surgery in management of gall bladder cancerCTRI/2018/02/011879I45
进行中（未招募）
不适用
Feasibility study of hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with stage III or only pleural stage IV ovarian carcinoma in first line therapy. - HIPEC-ovarian carcinomaInclusion criteria :1. Histologically confirmed ovarian carcinoma or primary peritoneal carcinoma or Fallopian tube carcinoma.2. FIGO stage III disease or only pleural stage IV disease3. Age less than 65 years4. ECOG performance status 0-1.5. Adequate bone marrow, hepatic and renal functions.6. No serious cardiac or respiratory illnessEUCTR2009-009467-59-BEInstitut Jules Bordet
尚未招募
3 期
EFFIPECColorectal cancer2024-516224-34-00Uppsala University163
进行中（未招募）
1 期
EFFIPECMedDRA version: 27.0Level: LLTClassification code: 10052362Term: Metastatic colorectal cancer Class: 10029104Colorectal cancerCTIS2024-516224-34-00ppsala University230
进行中（未招募）
1 期
Feasibility of a chemotherapy with the two agents Carboplatin and Paclitaxel, that is applied heated directly into the abdomen after surgery of patients with advanced cancer of the ovaryOtherwise treatment-naive patients with epithelial ovarian cancer, FIGO III - IVaEUCTR2012-003244-76-ATMedical University of Vienna20